William M. Krulak Jr. and Ariana K. DeJan-Lenoir of Miles & Stockbridge have entered appearances for vaccine manufacturer Emergent BioSolutions, its top officers and directors in a pending shareholder derivative lawsuit in connection with the drug company's production of COVID-19 vaccines for Johnson & Johnson and AstraZeneca. The action, filed Nov. 1 in Maryland District Court by the Kaplan Law Firm and Schubert Jonckheer & Kolbe on behalf of Richard J. Levine, contends that certain company insiders sold nearly $42 million of Emergent stock prior to public disclosure of control failures at Emergent's facility. The case, assigned to U.S. District Judge Deborah L. Boardman, is 8:23-cv-02969, Levine v. Kramer et al.
Biotech & Pharmaceuticals
November 30, 2023, 9:50 AM